Fra-2 mediates oxygen-sensitive induction of transforming growth factor β in cardiac fibroblasts

Cardiovascular Research

Volumn 87, Issue 4, 2010, Pages 647-655

  Roy, Sashwati ^a   Khanna, Savita ^a   Azad, Ali ^a   Schnitt, Rebecca ^a   He, Guanglong ^a   Weigert, Cora ^b   Ichijo, Hidenori ^c   Sen, Chandan K ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Oxygen; Reperfusion; TGF

Indexed keywords

APOPTOSIS SIGNAL REGULATING KINASE 1; OXYGEN; TRANSCRIPTION FACTOR FRA 2; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA3;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION; HEART MUSCLE; HEART MUSCLE FIBROSIS; HYPEROXIA; IN VIVO STUDY; LASER CAPTURE MICRODISSECTION; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BINDING SITES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FIBROBLASTS; FIBROSIS; FOS-RELATED ANTIGEN-2; HYPEROXIA; MAP KINASE KINASE KINASE 5; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; OXYGEN; PROMOTER REGIONS, GENETIC; RNA INTERFERENCE; TIME FACTORS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; UP-REGULATION;

EID: 77955872851     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq123     Document Type: Article

References (50)

1. Roy S, Khanna S, Rink T, Radtke J, Williams WT, Biswas S et al. P21waf1/cip1/sdi1 as a central regulator of inducible smooth muscle actin expression and differentiation of cardiac fibroblasts to myofibroblasts. Mol Biol Cell 2007;18:4837-4846.
2. Leask A. TGFbeta, cardiac fibroblasts, and the fibrotic response. Cardiovasc Res 2007; 74:207-212.
3. Lijnen P, Petrov V, Rumilla K, Fagard R. Transforming growth factor-beta 1 promotes contraction of collagen gel by cardiac fibroblasts through their differentiation into myofibroblasts. Methods Find Exp Clin Pharmacol 2003;25:79-86.
4. Seeland U, Haeuseler C, Hinrichs R, Rosenkranz S, Pfitzner T, Scharffetter-Kochanek K et al. Myocardial fibrosis in transforming growth factor-beta(1) (TGF-beta(1)) transgenic mice is associated with inhibition of interstitial col-lagenase. Eur J Clin Invest 2002;32:295-303.
5. Waltenberger J, Lundin L, Oberg K, Wilander E, Miyazono K, Heldin CH et al. Involvement of transforming growth factor-beta in the formation of fibrotic lesions in carci-noid heart disease. Am J Pathol 1993;142:71-78.
6. Letterio JJ, Roberts AB. Regulation of immune responses by TGF-beta. Annu Rev Immunol 1998;16:137-161.
7. Wen FQ, Kohyama T, Skold CM, Zhu YK, Liu X, Romberger DJ et al. Glucocorticoids modulate TGF-beta production. Inflammation 2002;26:279-290.
8. Roy S, Khanna S, Bickerstaff AA, Subramanian SV, Atalay M, Bierl M et al. Oxygen sensing by primary cardiac fibroblasts: a key role of p21(Waf1/Cip1/Sdi1). Circ Res 2003;92:264-271.
9. Roy S, Khanna S, Wallace WA, Lappalainen J, Rink C, Cardounel AJ et al. Characterization of perceived hyperoxia in isolated primary cardiac fibroblasts and in the reox-ygenated heart. J Biol Chem 2003;278:47129-47135.
10. Sen CK, Khanna S, Roy S. Perceived hyperoxia: oxygen-induced remodeling of the reoxygenated heart. Cardiovasc Res 2006;71:280-288.
11. Gnyawali SC, Roy S, McCoy M, Biswas S, Sen CK. Remodeling of the ischemia-reperfused murine heart: 11.7T cardiac magnetic resonance imaging of contrast enhanced infarct patches and transmurality. Antioxid Redox Signal 2009;11: 1829-1839.
12. Siaghy EM, Devaux Y, Sfaksi N, Carteaux JP, Ungureanu-Longrois D, Zannad F et al. Consequences of inspired oxygen fraction manipulation on myocardial oxygen pressure, adenosine and lactate concentrations: a combined myocardial microdialysis and sensitive oxygen electrode study in pigs. J Mol Cell Cardiol 2000;32:493-504.
13. Khanna S, Roy S, Maurer M, Ratan RR, Sen CK. Oxygen-sensitive reset of hypoxia-inducible factor transactivation response: prolyl hydroxylases tune the biological normoxic set point. Free Radic Biol Med 2006;40:2147-2154.
14. Kuhn DE, Roy S, Radtke J, Gupta S, Sen CK. Laser microdissection and pressure-catapulting technique to study gene expression in the reoxygenated myocardium. Am J Physiol Heart Circ Physiol 2006;290:H2625-H2632.
15. Kuhn DE, Roy S, Radtke J, Khanna S, Sen CK. Laser microdissection and capture of pure cardiomyocytes and fibroblasts from infarcted heart regions: perceived hyper-oxia induces p21 in peri-infarct myocytes. Am J Physiol Heart Circ Physiol 2007;292: H1245-H1253.
16. Zhang X, Azhar G, Nagano K, Wei JY. Differential vulnerability to oxidative stress in rat cardiac myocytes versus fibroblasts. J Am Coll Cardiol 2001;38:2055-2062.
17. Liao XD, Wang XH, Jin HJ, Chen LY, Chen Q. Mechanical stretch induces mitochondria-dependent apoptosis in neonatal rat cardiomyocytes and G2/M accumulation in cardiac fibroblasts. Cell Res 2004;14:16-26.
18. Roy S, Khanna S, Kuhn DE, Rink C, Williams WT, Zweier JL et al. Transcriptome analysis of the ischemia-reperfused remodeling myocardium: temporal changes in inflammation and extracellular matrix. Physiol Genomics 2006;25:364-374.
19. Ojha N, Roy S, Radtke J, Simonetti O, Gnyawali S, Zweier JL et al. Characterization of the structural and functional changes in the myocardium following focal ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2008;294:H2435-H2443.
20. Roy S, Khanna S, Hussain SR, Biswas S, Azad A, Rink C et al. MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc Res 2009;82: 21-29.
21. Roy S, Patel D, Khanna S, Gordillo GM, Biswas S, Friedman A et al. Transcriptome-wide analysis of blood vessels laser captured from human skin and chronic wound-edge tissue. Proc Natl Acad Sci USA 2007;104:14472-14477.
22. Roy S, Khanna S, Nallu K, Hunt TK, Sen CK. Dermal wound healing is subject to redox control. Mol Ther 2006;13:211-220.
23. Tobiume K, Saitoh M, Ichijo H. Activation of apoptosis signal-regulating kinase 1 by the stress-induced activating phosphorylation of pre-formed oligomer. J Cell Physiol 2002;191:95-104.
24. Weigert C, Sauer U, Brodbeck K, Pfeiffer A, Haring HU, Schleicher ED. AP-1 proteins mediate hyperglycemia-induced activation of the human TGF-beta1 promoter in mesangial cells. J Am Soc Nephrol 2000;11:2007-2016.
25. Hess J, Angel P, Schorpp-Kistner M. AP-1 subunits: quarrel and harmony among siblings. J Cell Sci 2004;117:5965-5973.
26. Jibiki I, Hashimoto S, Maruoka S, Gon Y, Matsuzawa A, Nishitoh H et al. Apoptosis signal-regulating kinase 1-mediated signaling pathway regulates nitric oxide-induced activator protein-1 activation in human bronchial epithelial cells. Am J Respir Crit Care Med 2003;167:856-861. (Pubitemid 36801773)
27. Porter KE, Turner NA. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol Ther 2009;123:255-278.
28. Roberts AB, Anzano MA, Lamb LC, Smith JM, Sporn MB. New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues. Proc Natl Acad Sci USA 1981;78:5339-5343.
29. Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 2006;24:99-146.
30. Kim SJ, Angel P, Lafyatis R, Hattori K, Kim KY, Sporn MB et al. Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex. Mol Cell Biol 1990;10: 1492-1497.
31. Kim SJ, Jeang KT, Glick AB, Sporn MB, Roberts AB. Promoter sequences of the human transforming growth factor-beta 1 gene responsive to transforming growth factor-beta 1 autoinduction. J Biol Chem 1989;264:7041-7045.
32. Van Obberghen-Schilling E, Roche NS, Flanders KC, Sporn MB, Roberts AB. Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells. J Biol Chem 1988;263:7741-7746.
33. Roberts AB, Sporn MB. Differential expression of the TGF-beta isoforms in embry-ogenesis suggests specific roles in developing and adult tissues. Mol Reprod Dev 1992;32:91-98.
34. Dubois CM, Laprise MH, Blanchette F, Gentry LE, Leduc R. Processing of transforming growth factor beta 1 precursor by human furin convertase. J Biol Chem 1995;270: 10618-10624.
35. Hyytiainen M, Penttinen C, Keski-Oja J. Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation. Crit Rev Clin Lab Sci 2004;41: 233-264.
36. Taylor AW. Review of the activation of TGF-{beta} in immunity. J Leukoc Biol 2009;85: 29-33.
37. Barcellos-Hoff MH, Dix TA. Redox-mediated activation of latent transforming growth factor-beta 1. Mol Endocrinol 1996;10:1077-1083.
38. Cheng F, Li Y, Feng L, Li S. Hepatic stellate cell activation and hepatic fibrosis induced by ischemia/reperfusion injury. Transplant Proc 2008;40:2167-2170.
39. Furuichi K, Gao JL, Murphy PM. Chemokine receptor CX3CR1 regulates renal interstitial fibrosis after ischemia-reperfusion injury. Am J Pathol 2006;169:372-387.
40. Bujak M, Frangogiannis NG. The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res 2007;74:184-195.
41. Nishina H, Sato H, Suzuki T, Sato M, Iba H. Isolation and characterization of fra-2, an additional member of the fos gene family. Proc Natl Acad Sci USA 1990;87:3619-3623.
42. Gruda MC, Kovary K, Metz R, Bravo R. Regulation of Fra-1 and Fra-2 phosphorylation differs during the cell cycle of fibroblasts and phosphorylation in vitro by MAP kinase affects DNA binding activity. Oncogene 1994;9:2537-2547.
43. Milde-Langosch K. The Fos family of transcription factors and their role in tumouri-genesis. Eur J Cancer 2005;41:2449-2461.
44. Andersen H, Mahmood S, Tkach V, Cohn M, Kustikova O, Grigorian M et al. The ability of Fos family members to produce phenotypic changes in epithelioid cells is not directly linked to their transactivation potentials. Oncogene 2002;21:4843-4848.
45. Zahradka P. Novel role for osteopontin in cardiac fibrosis. Circ Res 2008;102: 270-272.
46. Ibrahim EM, Stewart RL, Corke K, Blackett AD, Tidy JA, Wells M. Upregulation of CD44 expression by interleukins 1, 4, and 13, transforming growth factor-beta1, estrogen, and progestogen in human cervical adenocarcinoma cell lines. Int J Gynecol Cancer 2006;16:1631-1642.
47. Huebener P, Abou-Khamis T, Zymek P, Bujak M, Ying X, Chatila K et al. CD44 is critically involved in infarct healing by regulating the inflammatory and fibrotic response. J Immunol 2008;180:2625-2633.
48. Crawford SE, Stellmach V, Murphy-Ullrich JE, Ribeiro SM, Lawler J, Hynes RO et al. Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell 1998;93:1159-1170.
49. Belmadani S, Bernal J, Wei CC, Pallero MA, Dell'italia L, Murphy-Ullrich JE et al. A thrombospondin-1 antagonist of transforming growth factor-beta activation blocks cardiomyopathy in rats with diabetes and elevated angiotensin II. Am J Pathol 2007; 171:777-789.
50. Rouschop KM, Sewnath ME, Claessen N, Roelofs JJ, Hoedemaeker I, van der Neut R et al. CD44 deficiency increases tubular damage but reduces renal fibrosis in obstructive nephropathy. J Am Soc Nephrol 2004;15:674-686.